Dr. Audrey Chen Mok, MD

Dr. Mok practices at Eye Treatment Center, an Incorporated Medical Group, Inc in Long Beach, California.

Dr. Mok's NPI, 1134188519, was assigned on March 22, 2006. Dr. Mok graduated from Georgetown University School Of Medicine in 2000. Dr. Mok holds California license A86641.

Dr. Mok's primary practice is Eye Treatment Center, an Incorporated Medical Group, Inc, at 1045 Atlantic Ave, Long Beach, CA 90813 in Los Angeles County. The practice phone is (562) 988-8668.

Dr. Mok's primary practice is Eye Treatment Center, an Incorporated Medical Group, Inc in Long Beach, California. Dmand AI also links Dr. Mok to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mok practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mok's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mok is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Mok is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Mok treats.

CMS data shows 3,401 Medicare services from Dr. Mok across 25 procedure codes in 2024, for 976 Medicare patients. Medicare paid $253,258 for them.

CMS counts 976 Medicare patients who saw Dr. Mok in 2024. The largest group is 75 to 84, with 409 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mok's median patient age at 73, with 62% women.

In 2024, Dr. Mok wrote 2,880 Medicare Part D claims for 638 patients. 50% of them were for generic drugs. CMS names the drug for 2,740 of them, across 36 drugs with 11 or more claims each, at $638,786 in total drug cost. In 2023, CMS named 2,610 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mok for performance year 2024, reported as part of a group. Dr. Mok accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of cataract surgery by Dr. Mok, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Mok in 2020. 2020 was the busiest year, with 2. Dr. Mok's most frequent co-authors are Sean David Adrean, MD and Siyang Chaili, MD.

CMS Open Payments shows 565 general payments to Dr. Mok from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Alcon Laboratories Inc paid the most, $1,907.

Dmand AI lists 1 award for Dr. Mok.

Dr. Mok graduated from Georgetown University School Of Medicine in 2000. Dr. Mok is a member of AAO.

Dr. Mok is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.